PL1638933T3 - Pochodne n-pirolidyn-3-yloamidu jako inhibitory wychwytu zwrotnego serotoniny i noradrenaliny - Google Patents

Pochodne n-pirolidyn-3-yloamidu jako inhibitory wychwytu zwrotnego serotoniny i noradrenaliny

Info

Publication number: PL1638933T3
Authority: PL; Poland
Prior art keywords: noradrenaline; serotonin; pyrrolidin; amide derivatives; uptake inhibitors
Prior art date: 2003-06-17

Application number

PL04736241T

Other languages

English (en)

Inventor

Paul Vincent Fish

Michael Jonathan Fray

Alan Stobie

Florian Wakenhut

Gavin Alistair Whitlock

Alan Daniel Brown

Mark David Andrews;

Mark Ian Lansdell

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-17

Filing date

2004-06-07

Publication date

2008-10-31

2003-06-17 Priority claimed from GBGB0314048.0A external-priority patent/GB0314048D0/en

2004-06-07 Application filed by Pfizer filed Critical Pfizer

2008-10-31 Publication of PL1638933T3 publication Critical patent/PL1638933T3/pl

Links

QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 title 2
239000003112 inhibitor Substances 0.000 title 1
230000000966 norepinephrine reuptake Effects 0.000 title 1
NGXSWUFDCSEIOO-UHFFFAOYSA-N pyrrolidin-3-amine Chemical class NC1CCNC1 NGXSWUFDCSEIOO-UHFFFAOYSA-N 0.000 title 1
229940076279 serotonin Drugs 0.000 title 1
230000000697 serotonin reuptake Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Addiction (AREA)
Psychology (AREA)
Rheumatology (AREA)
Hematology (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Gynecology & Obstetrics (AREA)
Child & Adolescent Psychology (AREA)
Diabetes (AREA)
Anesthesiology (AREA)
Obesity (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyrrole Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)

PL04736241T 2003-06-17 2004-06-07 Pochodne n-pirolidyn-3-yloamidu jako inhibitory wychwytu zwrotnego serotoniny i noradrenaliny PL1638933T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GBGB0314048.0A GB0314048D0 (en)	2003-06-17	2003-06-17	Novel compounds
US49312603P	2003-08-06	2003-08-06
EP04736241A EP1638933B1 (en)	2003-06-17	2004-06-07	N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors
PCT/IB2004/001943 WO2004110995A1 (en)	2003-06-17	2004-06-07	N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors

Publications (1)

Publication Number	Publication Date
PL1638933T3 true PL1638933T3 (pl)	2008-10-31

Family

ID=33554153

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL04736241T PL1638933T3 (pl)	2003-06-17	2004-06-07	Pochodne n-pirolidyn-3-yloamidu jako inhibitory wychwytu zwrotnego serotoniny i noradrenaliny

Country Status (31)

Country	Link
US (2)	US7378436B2 (pl)
EP (1)	EP1638933B1 (pl)
JP (1)	JP4137159B2 (pl)
KR (1)	KR100803796B1 (pl)
AP (1)	AP2005003467A0 (pl)
AR (1)	AR044715A1 (pl)
AT (1)	ATE398107T1 (pl)
AU (1)	AU2004247487B2 (pl)
BR (1)	BRPI0411594A (pl)
CA (1)	CA2530159C (pl)
CY (1)	CY1110434T1 (pl)
DE (1)	DE602004014372D1 (pl)
DK (1)	DK1638933T3 (pl)
EA (1)	EA009881B1 (pl)
EC (1)	ECSP056232A (pl)
ES (1)	ES2305776T3 (pl)
HR (2)	HRP20050993A2 (pl)
IL (1)	IL172063A0 (pl)
IS (1)	IS8136A (pl)
MA (1)	MA27885A1 (pl)
MX (1)	MXPA05013960A (pl)
NL (1)	NL1026438C2 (pl)
NZ (1)	NZ544046A (pl)
PA (1)	PA8605301A1 (pl)
PE (1)	PE20050631A1 (pl)
PL (1)	PL1638933T3 (pl)
PT (1)	PT1638933E (pl)
SI (1)	SI1638933T1 (pl)
TW (1)	TW200505852A (pl)
UY (1)	UY28360A1 (pl)
WO (1)	WO2004110995A1 (pl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4898073B2 (ja) *	2000-07-31	2012-03-14	ニュコメデダンマルクアンパーツセルスカブ	鼻内投与用フェンタニル組成物
SI1638933T1 (sl) *	2003-06-17	2008-10-31	Pfizer	Derivati N-pirolidin-3-il-amida kot inhibitorji ponovnega privzema serotonina in noradrenalina
CN101094846A (zh)	2004-10-18	2007-12-26	伊莱利利公司	用作mglur3受体拮抗剂的1－(杂)芳基－3－氨基－吡咯烷衍生物
US7122683B2 (en)	2004-11-23	2006-10-17	Pfizer Inc.	Amides useful as monoamine re-uptake inhibitors
GB0425766D0 (en) *	2004-11-23	2004-12-22	Pfizer Ltd	Novel compounds
WO2006064332A1 (en) *	2004-12-14	2006-06-22	Pfizer Limited	N-pyrrolidin-3yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors
WO2006064336A2 (en) *	2004-12-14	2006-06-22	Pfizer Limited	N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors
TWI410406B (zh) *	2005-05-13	2013-10-01	Otsuka Pharma Co Ltd	吡咯烷化合物
EP1893603B1 (en) *	2005-06-02	2009-10-14	F. Hoffmann-La Roche AG	Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists
WO2007135530A2 (en) *	2006-05-22	2007-11-29	Pfizer Limited	Pharmaceutically & veterinarily suitable salt
US20080014152A1 (en) *	2006-07-13	2008-01-17	Di Mauro Thomas M	Intranasal delivery of clenbuterol across the cribriform plate and into the brain
JP5219465B2 (ja) *	2006-11-10	2013-06-26	大塚製薬株式会社	医薬
JPWO2008093737A1 (ja) *	2007-01-31	2010-05-20	大日本住友製薬株式会社	アミド誘導体
JP2010189275A (ja) *	2007-06-14	2010-09-02	Dainippon Sumitomo Pharma Co Ltd	ナフタレン誘導体
US8263652B2 (en)	2007-10-31	2012-09-11	Sk Biopharmaceuticals Co., Ltd.	Stabilized pediatric suspension of carisbamate
RU2010129690A (ru) *	2007-12-19	2012-01-27	Дайниппон Сумитомо Фарма Ко., Лтд. (Jp)	Бициклические гетероциклические производные
WO2010011811A2 (en)	2008-07-24	2010-01-28	Theravance, Inc.	3-(phenoxyphenylmethyl)pyrrolidine compounds
US8304433B2 (en)	2008-11-14	2012-11-06	Theravance, Inc.	Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
WO2010120910A1 (en) *	2009-04-15	2010-10-21	Theravance, Inc.	3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds
KR20120109292A (ko)	2009-06-24	2012-10-08	다이닛본 스미토모 세이야꾸 가부시끼가이샤	Ｎ-치환-시클릭 아미노 유도체
AU2010273645B2 (en) *	2009-07-13	2014-12-04	Theravance Biopharma R&D Ip, Llc	3-phenoxymethylpyrrolidine compounds
US8273786B2 (en)	2009-07-21	2012-09-25	Theravance, Inc.	3-phenoxymethylpyrrolidine compounds
WO2011085291A1 (en)	2010-01-11	2011-07-14	Theravance, Inc.	1 - (2 - phenoxymethylphenyl) piperazine compounds as serotonin and norepinephrine reuptake inhibitors
WO2011119461A1 (en) *	2010-03-22	2011-09-29	Theravance, Inc.	1-(2-phenoxymethylheteroaryl)piperidine and piperazine compounds
US8471040B2 (en)	2010-10-11	2013-06-25	Theravance, Inc.	Serotonin reuptake inhibitors
US8501964B2 (en)	2010-12-03	2013-08-06	Theravance, Inc.	Serotonin reuptake inhibitors

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE138773C (pl)
US3963745A (en) *	1972-04-03	1976-06-15	A. H. Robins Company, Incorporated	Method for controlling emesis with N-(1-substituted-3-pyrrolidinyl)benzamides and thiobenzamides
US4002757A (en) *	1974-12-26	1977-01-11	A. H. Robins Company, Incorporated	N-(1-substituted-3-pyrrolidinyl)-4-quinolinecarboxamides
US4020072A (en) *	1976-05-04	1977-04-26	E. R. Squibb & Sons, Inc.	5-Aminomethyl-1H-pyrazolo[3,4-b]pyridines
GB1574419A (en) *	1977-11-11	1980-09-03	Anphar Sa	Piperidine compounds
CH628885A5 (en) *	1978-01-01	1982-03-31	Anphar Sa	Piperidine derivative
US5130312A (en) *	1987-07-17	1992-07-14	Janssen Pharmaceutica N.V.	Substituted N-(3-hydroxy-4-piperidinyl)benzamides
FR2642069B1 (fr)	1989-01-20	1991-04-12	Rhone Poulenc Sante	Nouveaux derives du benzopyranne, leur preparation et les compositions pharmaceutiques qui les contiennent
CA2238081A1 (en)	1995-11-22	1997-05-29	S. Jane Desolms	Inhibitors of farnesyl-protein transferase
WO1999065881A1 (en)	1998-06-19	1999-12-23	Nissan Chemical Industries, Ltd.	Heterocyclic compounds as hypoglycemic agents
US6670299B1 (en) *	1999-07-03	2003-12-30	Northwestern University	Cyclopentadienyl-containing low-valent early transition metal olefin polymerization catalysts
FR2802206B1 (fr) *	1999-12-14	2005-04-22	Sod Conseils Rech Applic	Derives de 4-aminopiperidine et leur utilisation en tant que medicament
EP1311272B1 (en)	2000-03-03	2006-11-22	Eisai Co., Ltd.	Novel methods using cholinesterase inhibitors
ES2278729T3 (es) *	2000-03-06	2007-08-16	Acadia Pharmaceuticals Inc.	Compuestos azaciclicos para usar en el tratamiento de enfermedades relacionadas con la serotonina.
AU2001287898A1 (en)	2000-09-22	2002-04-02	Stephen Garland	Pyrazolopyridines and pyrazolopyridazines as antidiabetics
IL154363A0 (en)	2000-09-25	2003-09-17	Actelion Pharmaceuticals Ltd	Substituted amino-aza-cycloalkanes useful against malaria
EP1430027B1 (en)	2001-09-14	2010-09-01	High Point Pharmaceuticals, LLC	Novel aminoazetidine, -pyrrolidine and -piperidine derivatives
CA2468761A1 (en)	2001-10-31	2003-05-08	Morphochem Aktiengesellschaft Fuer Kombinatorische Chemie	Novel anticancer compounds
GB0128287D0 (en)	2001-11-26	2002-01-16	Smithkline Beecham Plc	Novel method and compounds
EP1562937A2 (en) *	2002-06-24	2005-08-17	Acadia Pharmaceuticals Inc.	N-substituted piperidine derivatives as serotonin receptor agents
AU2003249983A1 (en)	2002-07-18	2004-02-09	Actelion Pharmaceuticals Ltd	Piperidines useful for the treatment of central nervous system disorders
WO2004022536A1 (en)	2002-09-04	2004-03-18	Glenmark Pharmaceuticals Limited	New heterocyclic amide compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
ATE427933T1 (de)	2002-12-20	2009-04-15	Chemocentryx Inc	Inhibitoren der bindungder chemokine i-tac bzw. sdf-1 an den ccxckr2-rezeptor
SI1638933T1 (sl) *	2003-06-17	2008-10-31	Pfizer	Derivati N-pirolidin-3-il-amida kot inhibitorji ponovnega privzema serotonina in noradrenalina

2004
- 2004-06-07 SI SI200430767T patent/SI1638933T1/sl unknown
- 2004-06-07 ES ES04736241T patent/ES2305776T3/es not_active Expired - Lifetime
- 2004-06-07 JP JP2006516540A patent/JP4137159B2/ja not_active Expired - Fee Related
- 2004-06-07 MX MXPA05013960A patent/MXPA05013960A/es active IP Right Grant
- 2004-06-07 DK DK04736241T patent/DK1638933T3/da active
- 2004-06-07 KR KR1020057024147A patent/KR100803796B1/ko not_active Expired - Fee Related
- 2004-06-07 AP AP2005003467A patent/AP2005003467A0/xx unknown
- 2004-06-07 CA CA002530159A patent/CA2530159C/en not_active Expired - Fee Related
- 2004-06-07 NZ NZ544046A patent/NZ544046A/en unknown
- 2004-06-07 HR HR20050993A patent/HRP20050993A2/hr not_active Application Discontinuation
- 2004-06-07 AU AU2004247487A patent/AU2004247487B2/en not_active Expired - Fee Related
- 2004-06-07 EA EA200501730A patent/EA009881B1/ru not_active IP Right Cessation
- 2004-06-07 PT PT04736241T patent/PT1638933E/pt unknown
- 2004-06-07 WO PCT/IB2004/001943 patent/WO2004110995A1/en not_active Ceased
- 2004-06-07 PL PL04736241T patent/PL1638933T3/pl unknown
- 2004-06-07 DE DE602004014372T patent/DE602004014372D1/de not_active Expired - Lifetime
- 2004-06-07 EP EP04736241A patent/EP1638933B1/en not_active Expired - Lifetime
- 2004-06-07 AT AT04736241T patent/ATE398107T1/de not_active IP Right Cessation
- 2004-06-07 BR BRPI0411594-5A patent/BRPI0411594A/pt not_active IP Right Cessation
- 2004-06-07 HR HR20080339T patent/HRP20080339T3/xx unknown
- 2004-06-14 PE PE2004000590A patent/PE20050631A1/es not_active Application Discontinuation
- 2004-06-14 UY UY28360A patent/UY28360A1/es not_active Application Discontinuation
- 2004-06-16 TW TW093117317A patent/TW200505852A/zh unknown
- 2004-06-16 AR ARP040102082A patent/AR044715A1/es not_active Application Discontinuation
- 2004-06-16 PA PA20048605301A patent/PA8605301A1/es unknown
- 2004-06-17 US US10/872,160 patent/US7378436B2/en not_active Expired - Fee Related
- 2004-06-17 NL NL1026438A patent/NL1026438C2/nl not_active IP Right Cessation
2005
- 2005-11-20 IL IL172063A patent/IL172063A0/en unknown
- 2005-11-21 IS IS8136A patent/IS8136A/is unknown
- 2005-12-16 EC EC2005006232A patent/ECSP056232A/es unknown
- 2005-12-16 MA MA28674A patent/MA27885A1/fr unknown
2008
- 2008-05-21 US US12/124,755 patent/US20080306123A1/en not_active Abandoned
- 2008-08-14 CY CY20081100869T patent/CY1110434T1/el unknown

Also Published As

Publication number	Publication date
HRP20080339T3 (en)	2008-08-31
MXPA05013960A (es)	2006-02-24
AP2005003467A0 (en)	2006-12-31
NL1026438A1 (nl)	2004-12-20
IS8136A (is)	2005-11-21
NZ544046A (en)	2009-08-28
KR100803796B1 (ko)	2008-02-14
HRP20050993A2 (en)	2006-03-31
DE602004014372D1 (de)	2008-07-24
KR20060036927A (ko)	2006-05-02
WO2004110995A8 (en)	2005-04-21
ES2305776T3 (es)	2008-11-01
CA2530159A1 (en)	2004-12-23
EA200501730A1 (ru)	2006-08-25
US20080306123A1 (en)	2008-12-11
CA2530159C (en)	2010-02-02
ATE398107T1 (de)	2008-07-15
JP4137159B2 (ja)	2008-08-20
PA8605301A1 (es)	2005-02-04
SI1638933T1 (sl)	2008-10-31
MA27885A1 (fr)	2006-05-02
US20050137229A1 (en)	2005-06-23
NL1026438C2 (nl)	2005-09-20
EP1638933A1 (en)	2006-03-29
DK1638933T3 (da)	2008-07-28
UY28360A1 (es)	2005-01-31
CY1110434T1 (el)	2015-04-29
IL172063A0 (en)	2009-02-11
BRPI0411594A (pt)	2006-08-29
PE20050631A1 (es)	2005-09-14
AR044715A1 (es)	2005-09-21
AU2004247487B2 (en)	2010-05-20
US7378436B2 (en)	2008-05-27
TW200505852A (en)	2005-02-16
EP1638933B1 (en)	2008-06-11
PT1638933E (pt)	2008-07-22
AU2004247487A1 (en)	2004-12-23
EA009881B1 (ru)	2008-04-28
WO2004110995A1 (en)	2004-12-23
ECSP056232A (es)	2006-04-19
JP2006527758A (ja)	2006-12-07

Publication	Publication Date	Title
IL172063A0 (en)	2009-02-11	N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors
AP2048A (en)	2009-09-24	Diazepinoindole derivatives as kinase inhibitors
IL173381A0 (en)	2006-06-11	2-aminophenyl-4-phenylpyrimidines as kinase inhibitors
PL364580A1 (pl)	2004-12-13	Pochodne cyklopropyloindolu jako selektywne inhibitory zwrotnego wychwytu serotoniny
ZA200603233B (en)	2008-11-26	Dihydrobenzofuranyl alkanamine derivatives as 5HT 2c agonists
SI1492785T1 (sl)	2009-06-30	2-hidroksi-3-heteroarilindolni derivati kot inhibitorji GSK3
IS8806A (is)	2009-03-10	Fenýl-píperidín afleiður sem serótónín endurupptökuhindrar
AU2003271566A8 (en)	2004-03-03	Pyrrolopyrazines as kinase inhibitors
AU2003288444A1 (en)	2004-08-23	Methods and compositions for preventing fracture proppant flowback
IL172132A0 (en)	2006-04-10	Thienopyridone derivatives as kinase inhibitors
GB0325192D0 (en)	2003-12-03	Method of use
GB0314054D0 (en)	2003-07-23	Amide derivatives as selective serotonin re-uptake inhibitors
IL169323A0 (en)	2007-07-04	Pyrazole-derivatives as factor xa inhibitors
TWI368482B (en)	2012-07-21	New 2-pyridinylethylbenzamide derivatives
EP1667989A4 (en)	2008-08-20	SUBSTITUTED ISOQUINOLEINONES
PL360743A1 (pl)	2004-09-20	Pochodne fenoksybenzyloaminy jako selektywne inhibitory ponownego wychwytu serotoniny
PL374581A1 (pl)	2005-10-31	Diaminotiazole przydatne jako selektywne inhibitory CDK4
EP1670739A4 (en)	2007-08-08	CYCLIC DIAMINES AND DERIVATIVES AS FACTOR XA INHIBITORS
IL173521A0 (en)	2006-07-05	Substituted 2 - carbonylamino - 6 piperidinaminopyidines and substituted 1 - carbonylamino - 3 - piperidinaminobenzenes as 5 - th1f agonists
IL173904A0 (en)	2006-07-05	Combinations comprising alpha-2-delta ligands and serotonin/noradrenaline re-uptake inhibitors
IL172542A0 (en)	2006-04-10	2-hydroxymethyl-3,4,5-trihydroxy-1-benzilpiperidine derivatives as inhibitors of glucosylceramide
SI1377550T1 (en)	2005-02-28	Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
ZA200606070B (en)	2007-12-27	Substituted quinolines and their use as mycrobacterial inhibitors
IL176772A0 (en)	2006-10-31	Acylaminothiazole derivatives and use thereof as beta-amyloid inhibitors
ZA200703674B (en)	2008-09-25	Acylated nonadepsipeptides used as lysobactin derivatives